SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 35.99

Change

-2.67 (-6.91)%

Market Cap

N/A

Volume

0.97M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

-6.33 (-0.55%)

USD 127.14B
VRTX Vertex Pharmaceuticals Inc

-8.17 (-1.67%)

USD 125.27B
ALNY Alnylam Pharmaceuticals Inc

+4.09 (+1.51%)

USD 34.71B
ARGX argenx NV ADR

-15.72 (-2.92%)

USD 32.33B
MRNA Moderna Inc

+2.82 (+4.08%)

USD 26.25B
SMMT Summit Therapeutics PLC

-3.26 (-11.06%)

USD 23.47B
BGNE BeiGene Ltd

+1.06 (+0.54%)

USD 21.94B
RPRX Royalty Pharma Plc

-0.02 (-0.07%)

USD 16.45B
BMRN Biomarin Pharmaceutical Inc

+0.69 (+0.99%)

USD 16.16B
UTHR United Therapeutics Corporatio..

+0.04 (+0.01%)

USD 15.09B

ETFs Containing SWTX

BANK:CA Evolve Canadian Banks and.. 12.81 % 0.39 %

+0.02 (+0.11%)

CAD 0.24B
HFIN:CA Hamilton Enhanced Canadia.. 10.17 % 0.00 %

+0.02 (+0.11%)

CAD 0.16B
CEW:CA iShares Equal Weight Banc.. 9.71 % 0.60 %

+0.04 (+0.11%)

CAD 0.21B
FLI:CA CI U.S. & Canada Lifeco C.. 8.86 % 0.92 %

+0.03 (+0.11%)

CAD 0.09B
HEF:CA 7.65 % 0.83 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 3.61 % 0.00 %

+0.01 (+0.11%)

CAD 0.38B
CDEF:CA Manulife Smart Defensive .. 2.53 % 0.00 %

N/A

CAD 1.39M
HPR:CA Global X Active Preferred.. 1.80 % 0.63 %

-0.02 (0.11%)

CAD 1.05B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

-0.19 (0.11%)

N/A
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

+0.06 (+0.11%)

CAD 0.20B
BNC:CA 0.00 % 0.68 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.40% 61% D- 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.40% 61% D- 47% F
Trailing 12 Months  
Capital Gain 33.94% 74% C 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.94% 74% C 83% B
Trailing 5 Years  
Capital Gain 50.90% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.90% 80% B- 72% C
Average Annual (5 Year Horizon)  
Capital Gain 27.32% 75% C 82% B
Dividend Return 27.32% 75% C 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.39% 42% F 23% F
Risk Adjusted Return 35.30% 87% B+ 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector